18 results match your criteria: "International Centre for Antimicrobial Resistance Solutions[Affiliation]"
PLoS Negl Trop Dis
November 2024
Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa.
The diagnosis of anthrax, a zoonotic disease caused by Bacillus anthracis can be complicated by detection of closely related species. Conventional diagnosis of anthrax involves microscopy, culture identification of bacterial colonies and molecular detection. Genetic markers used are often virulence gene targets such as B.
View Article and Find Full Text PDFGlobal Health
August 2024
Global Strategy Lab, Dahdaleh Institute for Global Health Research, York University, 4700 Keele Street, Dahdaleh Building 2120, Toronto, M3J 2S5, Canada.
The Bellagio Group for Accelerating AMR Action met in April 2024 to develop the ambitious but achievable 1-10-100 unifying goals to galvanize global policy change and investments for antimicrobial resistance mitigation: 1 Health; 10 million lives saved; and 100% sustainable access to effective antimicrobials. High profile political goals such as the Paris Agreement's objective to keep global warming well below 2° Celsius compared to pre-industrial levels, UNAIDS' 90-90-90 goal, and the Sustainable Development Goals challenge global norms, direct attention towards relevant activities, and serve an energizing function to motivate action over an extended period of time. The 1-10-100 unifying goals propose to unite the world through a One Health approach to safeguard human health, animal welfare, agrifood systems, and the environment from the emergence and spread of drug-resistant microbes and infections; save over 10 million lives by 2040 through concerted efforts to prevent and appropriately treat infections while preserving the vital systems and services that depend on sustained antimicrobial effectiveness; and commit to ensuring that antimicrobials are available and affordable for all, used prudently, and secured for the future through innovation.
View Article and Find Full Text PDFAntimicrob Resist Infect Control
August 2024
Médecins Sans Frontières, Operational Centre Amsterdam (OCA), Amsterdam, The Netherlands.
Background: Antimicrobial resistance is of great global public health concern. In order to address the paucity of antibiotic consumption data and antimicrobial resistance surveillance systems in hospitals in humanitarian settings, we estimated antibiotic consumption in six hospitals with the aim of developing recommendations for improvements in antimicrobial stewardship programs.
Methods: Six hospitals supported by Médecins sans Frontières were included in the study: Boost-Afghanistan, Kutupalong-Bangladesh, Baraka and Mweso-Democratic Republic of Congo, Kule-Ethiopia, and Bentiu-South Sudan.
Lancet Microbe
November 2024
Antimicrobial Resistance Division, WHO, Geneva, Switzerland.
The WHO research agenda for antimicrobial resistance (AMR) in human health has identified 40 research priorities to be addressed by the year 2030. These priorities focus on bacterial and fungal pathogens of crucial importance in addressing AMR, including drug-resistant pathogens causing tuberculosis. These research priorities encompass the entire people-centred journey, covering prevention, diagnosis, and treatment of antimicrobial-resistant infections, in addition to addressing the overarching knowledge gaps in AMR epidemiology, burden and drivers, policies and regulations, and awareness and education.
View Article and Find Full Text PDFInfect Genet Evol
September 2024
Unit for Environmental Sciences and Management, Microbiology, North-West University, Potchefstroom, South Africa.
Priestia is a genus that was renamed from the genus Bacillus based on the conserved signature indels (CSIs) in protein sequences that separate Priestia species from Bacillus, with the latter only including species closely related to B. subtilis and B. cereus.
View Article and Find Full Text PDFBull World Health Organ
June 2024
International Centre for Antimicrobial Resistance Solutions, Copenhagen, Denmark.
Objective: To determine whether adding urine culture to urinary tract infection diagnosis in pregnant women from refugee camps in Lebanon reduced unnecessary antibiotic use.
Methods: We conducted a prospective, cross-sectional study between April and June 2022 involving pregnant women attending a sexual reproductive health clinic in south Beirut. Women with two positive urine dipstick tests (i.
Clin Microbiol Infect
July 2024
Department of Intensive Care Medicine, Radboudumc, Nijmegen, the Netherlands.
Facial Plast Surg Aesthet Med
July 2024
Médecins Sans Frontières, Noma Children's Hospital, Sokoto, Nigeria.
Noma is a gangrenous infection of the face that results in severe facial deformity, occurring primarily in malnourished and impoverished populations. To assess clinician- and patient-reported outcomes (PROs) before and after reconstructive surgery for patients with noma in northwest Nigeria. Objective outcomes were recorded using the noma-specific NOITULP (nose, outer cheek, inner cheek, trismus, upper/lower lip, particularities) classification system.
View Article and Find Full Text PDFLancet Glob Health
February 2024
Antimicrobial Research Unit, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa; International Centre for Antimicrobial Resistance Solutions (ICARS), Copenhagen, Denmark.
Oxf Med Case Reports
July 2023
Antimicrobial Resistance Unit, Médecins Sans Frontieres, Operational Center Geneva, Geneva, Switzerland.
Yeast-related bloodstream infections (BSIs) in pediatric patients are associated with severe acute malnutrition (SAM), hematological/oncological malignancies and admission to an intensive care unit. These infections are rarely described from low- and middle-income countries. We describe a case series of pediatric patients diagnosed with severe sepsis and yeast isolated from their blood culture in a conflict-affected area of Nigeria from October 2018 to November 2021.
View Article and Find Full Text PDFJAC Antimicrob Resist
April 2023
ICARS, International Centre for Antimicrobial Resistance Solutions, Ørestads Boulevard 5, Copenhagen 2300, Denmark.
Despite the escalating burden of antimicrobial resistance (AMR), the global response has not sufficiently matched the scale and scope of the issue, especially in low- and middle-income countries (LMICs). While many countries have adopted national action plans to combat AMR, their implementation has lagged due to resource constraints, dysfunctional multisectoral coordination mechanisms and, importantly, an under-recognized lack of technical capacity to adapt evidence-based AMR mitigation interventions to local contexts. AMR interventions should be tailored, context-specific, cost-effective and sustainable.
View Article and Find Full Text PDFJAC Antimicrob Resist
December 2022
British Society for Antimicrobial Chemotherapy, Birmingham, UK.
In 2015, 196 countries formally committed to a Global Action Plan to address antimicrobial resistance (AMR). However, translating policy into practice is not happening at pace and the recent Global Research on AntiMicrobial resistance (GRAM) Project report confirms the burden of AMR is increasing. Despite progress in establishing surveillance data and investment in new antimicrobials, education and training including use of behavioural science approaches to change practice is lagging.
View Article and Find Full Text PDFEur J Gen Pract
December 2022
Jaume I Health Centre, University Rovira i Virgili, Tarragona, Spain.
Background: A doctor may recommend that a patient stop an antibiotic course before its scheduled completion time if further treatment may cause more harm than benefit.
Objectives: This study explores general practitioners' (GP) opinions about the use of antibiotic deprescribing (AD) in general practice.
Methods: A cross-sectional, questionnaire-based study answered from February to March 2022.
Vaccine
October 2022
Department of Pediatrics, Section of Infectious Diseases, and Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA. Electronic address:
This is a Brighton Collaboration case definition of thrombosis and thromboembolism to be used in the evaluation of adverse events following immunization, and for epidemiologic studies for the assessment of background incidence or hypothesis testing. The case definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of SARS-CoV-2 vaccines. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation.
View Article and Find Full Text PDFDis Model Mech
July 2022
Department of Science, International Centre for Antimicrobial Resistance Solutions, Ørestads Boulevard 5, 2300 Copenhagen, Denmark.
JAC Antimicrob Resist
December 2021
National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.
One of the key drivers of antibiotic resistance (ABR) and drug-resistant bacterial infections is the misuse and overuse of antibiotics in human populations. Infection management and antibiotic decision-making are multifactorial, complex processes influenced by context and involving many actors. Social constructs including race, ethnicity, gender identity and cultural and religious practices as well as migration status and geography influence health.
View Article and Find Full Text PDFTrans R Soc Trop Med Hyg
October 2021
Institute of Infection and Immunity, Canadian Institutes of Health Research.
J Glob Antimicrob Resist
June 2021
Institute of Infection and Immunity, Canadian Institutes of Health Research, Canada. Electronic address:
Antimicrobial resistance must be recognised as a global societal priority - even in the face of the worldwide challenge of the COVID-19 pandemic. COVID-19 has illustrated the vulnerability of our healthcare systems in co-managing multiple infectious disease threats as resources for monitoring and detecting, and conducting research on antimicrobial resistance have been compromised during the pandemic. The increased awareness of the importance of infectious diseases, clinical microbiology and infection control and lessons learnt during the COVID-19 pandemic should be exploited to ensure that emergence of future infectious disease threats, including those related to AMR, are minimised.
View Article and Find Full Text PDF